Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy

Tuberous sclerosis complex (TSC) is a genetic disease in which overactivation of mechanistic target of rapamycin (mTOR) signaling leads to the growth of benign hamartomas in multiple organs, including the brain, and is associated with a high rate of epilepsy and neurological deficits. The mTOR inhib...

Descripción completa

Detalles Bibliográficos
Autor principal: Wheless, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543076/
https://www.ncbi.nlm.nih.gov/pubmed/26543807
http://dx.doi.org/10.1016/j.ebcr.2015.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543076/
https://www.ncbi.nlm.nih.gov/pubmed/26543807
http://dx.doi.org/10.1016/j.ebcr.2015.06.008

Ejemplares similares